ReviewAnnals of translational medicine2021

Evaluating safety and compatibility of anti-tumor necrosis factor therapy in patients with connective tissue disorders.

Jordan T Said et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.